Qiming Venture Partners’ Portfolio Company APT Medical Listed on STAR Board of Shanghai Stock Exchange

PR Newswire

SHANGHAI, Jan. 7, 2021 /PRNewswire/ — Qiming Venture Partners’ portfolio company APT Medical (SHSE: 688617) today successfully listed on the Science and Technology Innovation Board (the STAR Board) of Shanghai Stock Exchange. The issue price is CNY 74.46 per share. The stock opened at CNY 221.73 per share and closed at CNY 257.02 on the first trading day, up 245.18%, with a market cap of CNY 17.14 billion, or USD 2.65 billion.

Qiming is an A round investor and the largest institutional shareholder of APT Medical. Qiming’s RMB and USD funds combined own 19.35% of the company after the IPO.

The listing of APT Medical is the 13th successful public listing in Qiming Venture Partners’ portfolio in the past 12 months.

Founded in 2002, APT Medical provides coronary artery access and electrophysiological medical devices, peripheral blood vessels and nerve intervention medical devices, among others. APT Medical now is the domestic leader in China market and is expanding internationally. In 2019, APT Medical ranked No.1 in market share among domestic electrophysiological medical devices and ranked the third among domestic coronary artery medical devices, both in terms of sales amount, according to a Frost & Sullivan report.

“It’s our pleasure to support APT Medical to grow to a leading developer for minimally invasive cardiovascular interventional devices in China. Today the world is looking for better affordable care. APT has been investing heavily to design and produce products with better performance and at more affordable cost. We will continue to support APT and look forward to more exciting products.” said William Hu, Managing Partner of Qiming Venture Partners.

About Qiming Venture Partners

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Shenzhen, Hong Kong, Seattle, Boston and the San Francisco Bay Area.

Currently Qiming Venture Partners manages nine US Dollar funds and six RMB funds with over $5.6 billion assets under management. Since our establishment, we have invested in outstanding companies in the TMT and healthcare industries at the early and growth stages.

Since our debut, we have backed over 370 fast-growing and innovative companies. Over 120 companies are already listed on NYSE, NASDAQ, HKEx, Gretai Securities Market, Shanghai Stock Exchange and Shenzhen Stock Exchange, or achieved exit through M&A and other means. There are also over 30 portfolio companies that have achieved unicorn status.

Many of our portfolio companies are today’s most influential firms in their respective sectors, including Xiaomi (SEHK:1810), Meituan (SEHK:3690), Bilibili (NASDAQ:BILI), Roborock (SHSE:688169), Gan & Lee Pharmaceuticals (SHSE: 603087), Tigermed (SZSE:300347, SEHK:3347), Zai Lab (NASDAQ:ZLAB, SEHK:9688), Venus MedTech (SEHK:2500), CanSino Biologics (SEHK:6185, SHSE:688185), Schrödinger (NASDAQ:SDGR), APT Medical(SHSE:688617), Sanyou Medical (SHSE:688085), AmoyDx (SZSE:300685), Berry Genomics (SZSE:000710), SinocellTech (SHSE: 688520), WeDoctor Group, and UBTech among many others.

Cision View original content:http://www.prnewswire.com/news-releases/qiming-venture-partners-portfolio-company-apt-medical-listed-on-star-board-of-shanghai-stock-exchange-301202599.html

SOURCE Qiming Venture Partners

Veoneer estimates full year 2020 total order book and new order intake

PR Newswire

STOCKHOLM, Jan. 7, 2021 /PRNewswire/ — The automotive technology company Veoneer, Inc. (NYSE: VNE) and (SSE: VNE SDB) estimates its current total order book value for full year 2020 to be approximately $14 billion. During 2020, Veoneer divested its brake control business with an estimated order book value of around $4 billion, which is excluded from the current estimate. Reductions in the expectations for the global light vehicle production until 2025 further reduced the order book estimate by about $1 billion compared to the estimate from one year ago.

Lifetime value of the new order intake for the full year 2020 is estimated to be approximately $2.6 billion, corresponding to an average annual new order intake value of around $530 million, of which around 65% is for Active Safety orders. Despite the generally lower order activity in the market resulting from the COVID-19 pandemic, this new order intake value represents an increase of around 10% compared to the 2019 new order intake.

Veoneer estimates its share of Active Safety orders for 2020 to be around 15%, which is above its current sales market share. Due to the COVID-19 pandemic, the Company further estimates that the total Active Safety sourcing for 2020 was reduced by more than 40% compared to the expectations at the beginning of 2020.

As previously communicated, Veoneer expects to report a return to Organic sales growth in the fourth quarter of 2020 and a return to growth over the market for the second half of 2020.  It also expects the organic sales growth to accelerate in 2021.

Veoneer earnings report for the fourth quarter of 2020 is currently planned for Wednesday, February 3, 2021.

This report is information that Veoneer, Inc. is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the EVP Communications and IR set out above, at 08:30 CET on Thursday January 7, 2021. 

Definitions:

Order Book – Estimated total future sales attributable to documented new business awarded, based on estimated product volumes and pricing and exchange rates.

Order Intake – Estimated future average annual sales attributable to documented new business awarded based on estimated average annual product volumes, average annual sales price for such products, and exchange rates.

Lifetime Order Value – Estimated total lifetime sales attributable to documented new business awarded based on estimated product volumes and pricing, and exchange rates.

Organic Sales and Organic Sales Growth – Represent the increase or decrease in the overall U.S. dollar net sales and percentage change on a comparable basis thereby excluding any structural impacts. This facilitates separate discussions of the impact of acquisitions and divestitures and exchange rates on the Company’s performance.

For more information please contact:

Media:

Thomas Jönsson, Communications & IR, [email protected] , tel +46 (0)8 527 762 27

Investors & analysts:

Thomas Jönsson, Communications & IR, [email protected] , tel +46 (0)8 527 762 27
Ray Pekar, Investor Relations, [email protected] , tel +1 (248) 794-4537


Veoneer

designs, develops, manufactures and sells products and solutions for Active Safety, Autonomous Driving, and Occupant Protection. Our purpose is to create trust in mobility. Veoneer is a new technology company that is building on a heritage of more than 60 years of automotive safety development. Veoneer and its joint-ventures has 7,400 employees in 12 countries. Headquartered in Stockholm, Sweden, Veoneer is listed on the New York Stock Exchange and on Nasdaq Stockholm.


Safe Harbor Statement:


 This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this report other than statements of historical fact, including without limitation, statements regarding management’s examination of historical operating trends and data, estimates of future sales (including estimates related to order intake and order book), organic sale and organic sales growth or other future operating performance or financial results, are forward-looking statements. In some cases, you can identify these statements by forward-looking words such as “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” “may,” “likely,” “might,” “would,” “should,” “could,” or the negative of these terms and other comparable terminology, although not all forward-looking statements contain such words. We have based these forward-looking statements on our current expectations and assumptions and/or data available from third parties about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives and financial needs.


New risks and uncertainties arise from time to time, and it is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. Factors that could cause actual results to differ materially from these forward-looking statements include, without limitation, the following: general economic conditions; the cyclical nature of automotive sales and production; changes in general industry and market conditions or regional growth or decline; further decreases in light vehicle production; impact of COVID-19 on our customers and their production and product launch schedules; impact of COVID-19 on the Company’s financial condition, business operations and liquidity; impact of COVID-19 on our suppliers and availability of components for our products; our ability to complete the transaction contemplated by the non-binding agreement with Qualcomm Technologies, which is subject to the negotiation and documentation of a definitive agreement; the development of the software and integrated platform contemplated by the non-binding agreement with Qualcomm Technologies; our ability to achieve the intended benefits from our separation from our former parent; our ability to be awarded new business or loss of business from increased competition; higher than anticipated costs and use of resources related to developing new technologies; higher raw material, energy and commodity costs; component shortages; changes in customer and consumer preferences for end products; market acceptance of our new products; dependence on and relationships with customers and suppliers; our ability to share RD&E costs with our customers; unfavorable fluctuations in currencies or interest rates among the various jurisdictions in which we operate; costs or difficulties related to the integration of any new or acquired businesses and technologies; successful integration of acquisitions and operations of joint ventures; successful implementation of strategic partnerships and collaborations; product liability, warranty and recall claims and investigations and other litigation and customer reactions thereto; higher expenses for our pension and other post-retirement benefits, including higher funding needs for our pension plans; work stoppages or other labor issues; possible adverse results of future litigation, regulatory actions or investigations or infringement claims; our ability to protect our intellectual property rights; tax assessments by governmental authorities and changes in our tax rate; dependence on key personnel; legislative or regulatory changes impacting or limiting our business; political conditions; and other risks and uncertainties contained in the Company’s quarterly reports and Annual Report on Form 10-K.


For any forward-looking statements contained in this report or any other document, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we assume no obligation to revise or publicly release the results of any revision to these forward-looking statements, except as required by law. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/veoneer/r/veoneer-estimates-full-year-2020-total-order-book-and-new-order-intake,c3264718

The following files are available for download:

 

Cision View original content:http://www.prnewswire.com/news-releases/veoneer-estimates-full-year-2020-total-order-book-and-new-order-intake-301202593.html

SOURCE Veoneer

Book shares the journals of a Title I middle school teacher

‘Why I Teach’ by Bryan Johnson gets new marketing campaign

OKLAHOMA CITY, Jan. 07, 2021 (GLOBE NEWSWIRE) — Bryan Johnson ventures in the world of publishing to give readers a glimpse into the life of middle school teachers in a Title I school where 98% of the students receive free lunches. In his book, “Why I Teach” (published by Xlibris in August 2019), he sheds light on the challenges they faced and the sacrifices they made to teach their students to the best of their ability.

 

Set for a new marketing campaign, the book is a compilation of journals during the one-year-and-a half that Johnson taught in Oklahoma City Public Schools. As a social studies teacher who teaches U.S. history and geography, what better way to illustrate the importance of writing than to do it himself?

 

“I’ve always suggested to my students to be the first to write a book about their day-to-day activities in middle school and maybe they would be recognized for their efforts, but none of them have taken me up on it yet,” the author writes. “I decided to do it myself to maybe light the fire under one of them to show how easy it is and maybe after seeing the final product then maybe one of my students would accept the challenge.”

 

 “Why I Teach” offers a bird’s eye view of what it is like to be a middle school teacher in a Title I school. With the book, Johnson hopes to incite a deeper appreciation toward teachers and to inform those thinking of getting in this profession what they need to prepare as they enter the teaching environment.

 

To purchase and know more about the book, visit https://www.amazon.com/Why-Teach-Mid-High-Teachers-Journal/dp/1796049808.

 

“Why I Teach”

By Bryan Johnson

Hardcover | 6 x 9in | 494 pages | ISBN 9781796049817

Softcover | 6 x 9in | 494 pages | ISBN 9781796049800

E-Book | 494 pages | ISBN 9781796049794

Available at Amazon and Barnes & Noble

 

About the Author

Bryan Johnson is a retired from the U.S. Army after serving 20 years as a military police officer. He started his career as a private E-1, rose to the rank of sergeant (E-5), commissioned through Army ROTC at California State University, Long Beach, and retired at the rank of captain. Since retiring as an Army officer, Johnson went on to serve as a counselor at Boys Home, a police officer with the Oklahoma City Police Department, and a corrections officer at the Oklahoma Department of Corrections. He taught middle school social studies for 18 years and retired due to prostate cancer and other health issues. He is also working on a second book titled “Why I Teach-The Road Less Travelled.”

 

Xlibris Publishing, an Author Solutions, LLC imprint, is a self-publishing services provider created in 1997 by authors, for authors. By focusing on the needs of creative writers and artists and adopting the latest print-on-demand publishing technology and strategies, we provide expert publishing services with direct and personal access to quality publication in hardcover, trade paperback, custom leather-bound and full-color formats. To date, Xlibris has helped to publish more than 60,000 titles. For more information, visit xlibris.com or call 844-714-8691 to receive a free publishing guide.

Attachment



Marketing Services
XlibrisUS
844-714-8691
[email protected]

New book shares original songs and photos inspired by the most beautiful road in Virginia

Clare Reed announces the release of ‘7 West Through the Blue Ridge’

CINCINNATI, Jan. 07, 2021 (GLOBE NEWSWIRE) — “As different things happened in my life, the words and music popped into my head. I felt like the Lord gave me these songs and wants me to share them,” Clare Reed states. In “7 West Through the Blue Ridge” (published by AuthorHouse), she shares seven original songs that she has written and photos that she took  from the towns along Route 7 from Leesburg to Winchester, inspired by the most beautiful road in Virginia.

 

Route 7 is an old rural highway in extreme northern Virginia. Although it runs from Alexandria at the edge of the Potomac River to Winchester on the west side of the Blue Ridge Mountains, the interesting part goes from Leesburg to Winchester. It has physical beauty, historic towns, the occasional old-time restaurant or hardware store, and people who are trying to live their lives the right way regardless of their circumstances.

 

“This book will appeal to readers because of all the interesting places, pictures, and music that will touch the hearts of everyone who reads it.  Its overall theme includes love of God, love of music, happy times in childhood, and songs from my heart that tell stories of my life,” Reed says.

 

When asked what she wants readers to take away from the book, Reed answers, “Music speaks to everyone in different ways. I pray that the words and music in these songs bless everyone who reads them. I hope you enjoy these songs as much as I have. Believe me, they are from the heart because that is the only way I know how to write them. That is the way the Lord has given them to me.” For more details about the book, please visit https://www.authorhouse.com/en/bookstore/bookdetails/380149-7-west-through-the-blue-ridge

 

“7 West Through the Blue Ridge”

By Clare Reed

Softcover | 8.25 x 11in | 52 pages | ISBN 9781728351650

E-Book | 52 pages | ISBN 9781728351636

Available at Amazon and Barnes & Noble

 

About the Author

Born and raised in Cincinnati, Ohio, Clare Reed began her music career swinging on the backyard swing. Words and music just seemed to flow together. She later studied voice and sang in church and school functions. Singing was all she ever really thought of doing. However, her love for a family took her on a long detour, but the love of music was never far behind. Her life has taken her from Cincinnati to California and in 1977, to the Blue Ridge Mountains of Virginia.

 

AuthorHouse, an Author Solutions, Inc. self-publishing imprint, is a leading provider of book publishing, marketing, and bookselling services for authors around the globe and offers the industry’s only suite of Hollywood book-to-film services. Committed to providing the highest level of customer service, AuthorHouse assigns each author personal publishing and marketing consultants who provide guidance throughout the process. Headquartered in Bloomington, Indiana, AuthorHouse celebrates over 23 years of service to authors. For more information or to publish a book visit authorhouse.com or call 833-262-8899.

Attachment



Marketing Services
AuthorHouse
833-262-8899
[email protected]

When a hired assassin murdered his little brother, one man goes undercover to seek vengeance and justice

Robert Sandilands announces the release of ‘The Bomb Maker’s Apprentice’

GLASGOW, Scotland, Jan. 07, 2021 (GLOBE NEWSWIRE) — “I always carried a notebook and pen, constantly writing my experiences, describing scenes and people. I could say I was a natural storyteller, which earned me a few smacks on the head at school. I never thought I was good enough to get anything published and when I retired and had time on my hands, I thought what the hell, go for it,” Robert Sandilands states. In “The Bomb Maker’s Apprentice” (published by AuthorHouse UK) he tells the story of a man who wants to get vengeance and justice by going undercover in a criminal organization when an assassin murdered his little brother.

 

A hired assassin killed Richard Barton’s younger brother. While wading through his own grief, Richard’s parents pressure him to find this killer and bring closure to the family tragedy. To do so, Richard must walk a dark path and join a criminal organization. It takes months of violent tests and trials for Richard to finally get inside as part of the team.

 

As an ex-soldier, Richard thinks he has witnessed the worst of humanity, but he is wrong. The brutality he now sees, surrounded by villains, is more horrible than he could have imagined. If he wants justice, he might have to become monstrous himself. More than that, he must be careful and not ask too many questions because the wrong question could mean death.

 

“This is a fast moving thriller. You will never know what will happen in the next page, down to earth and to the point,” Sandilands says. When asked what he wants readers to take away from the book, he adds, “A pleasure of reading a good thriller.” For more details about the book, please visit https://www.authorhouse.com/en-gb/bookstore/bookdetails/770291-the-bomb-makers-apprentice

 

“The Bomb Maker’s Apprentice”

By Robert Sandilands

Hardcover | 6 x 9in | 230 pages | ISBN 9781665582865

Softcover | 6 x 9in | 230 pages | ISBN 9781665582858

E-Book | 230 pages | ISBN 9781665582841

Available at Amazon and Barnes & Noble

 

About the Author

After leaving school at the age of 15, Robert Sandilands entered the mining industry. He eventually spent years in the British Armed Forces and eventually drove trucks long distance. He always carried a notebook and pen, recording his experiences and describing scenes and people. Now retired, he dedicates his time to writing.

 

AuthorHouse, an Author Solutions, Inc. self-publishing imprint, is a leading provider of book publishing, marketing, and bookselling services for authors around the globe and offers the industry’s only suite of Hollywood book-to-film services. Committed to providing the highest level of customer service, AuthorHouse assigns each author personal publishing and marketing consultants who provide guidance throughout the process. Headquartered in Bloomington, Indiana, AuthorHouse celebrates over 23 years of service to authors. For more information or to publish a book visit authorhouse.co.uk or call 0-800-014-8641.

Attachment



Marketing Services
AuthorHouseUK
0-800-014-8641
[email protected]

Skanska builds Orlando Health Jewett Orthopedic Institute in Florida, USA, for about USD 64M, about SEK 524M

PR Newswire

ÖSTERSUND, Sweden, Jan. 7, 2021 /PRNewswire/ — Skanska has signed a contract with Orlando Health, Inc. to construct the new Orlando Health Jewett Orthopedic Institute in Orlando, Florida, USA. The contract is worth about USD 64M, about SEK 524M, which will be included in the US order bookings for the fourth quarter 2020.

The new 371,000-square-foot (about 35,000 sqm) institute will include an eight-story hospital that will house 75 inpatient rooms and 10 operating rooms (ORs). An adjoining 6-story medical office building will include two floors of ambulatory suites which will contain an added 12 ORs. The inpatient and outpatient facility will be dedicated solely to the care of orthopedic patients.

Construction began November 2020, and completion is scheduled for the second quarter of 2023.

Skanska is one of the leading construction and development companies in USA, specializing in building construction, civil infrastructure and developing commercial properties in select U.S. markets. Skanska USA had sales of SEK 74 billion and about 7,900 employees in its operations in 2019.

CONTACT:

For further information please contact:

Maritza E. Ferreira, Communications Director, Skanska USA, tel +1 (404) 946 75 21

Jacob Birkeland, Head of Media Relations & Public Affairs, Skanska AB, tel +46 (0)10 449 31 34

Direct line for media, tel +46 (0)10 448 88 99

This and previous releases can also be found at

www.skanska.com
.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/skanska/r/skanska-builds-orlando-health-jewett-orthopedic-institute-in-florida–usa–for-about-usd-64m–about-,c3264698

The following files are available for download:


https://mb.cision.com/Main/95/3264698/1356614.pdf

20210107 US Orthopedic Institute


https://news.cision.com/skanska/i/image-orlando-health-jewett-rendering—image-cred-eyp-architecture-engineering,c2865345

Image Orlando Health Jewett Rendering – image cred EYP Architecture Engineering

 

Cision View original content:http://www.prnewswire.com/news-releases/skanska-builds-orlando-health-jewett-orthopedic-institute-in-florida-usa-for-about-usd-64m-about-sek-524m-301202576.html

SOURCE Skanska

New book reveals the messages of archangel Michael about the future of humanity

Michele Baker announces the release of her spiritual book ‘All We Need Is Love’

JACKSON, Miss., Jan. 07, 2021 (GLOBE NEWSWIRE) — Michele Baker shares the messages she has received from archangel Michael — and other beings — on how to navigate the tumultuous but exciting times ahead in her new book “All We Need Is Love” (published by Balboa Press).

 

When she was in her late 30s, Baker started hearing messages from angels, ancestors, spirit guides and sentient beings from other worlds. The majority of the messages come from archangel Michael, chief of the angels. She began recording the messages through automatic writing — taking a pen and a notebook and writing whatever came out —  and was astounded when the words she was writing down began to come true.

 

The book relays that everyone on Earth and beyond is connected. It also explains that humanity is moving toward a higher level of consciousness and that this process of enlightenment has been occurring for thousands of years, but as the breakthrough gets ever closer, things are speeding up.

 

“I’m here to show you what’s possible now and to be a living example of the next step,” Baker says. “You are nothing less than a divine spark temporarily residing inside a human body, and your divine birthright is to co-create and have an amazing experience.”

 

To know more about the book, please visit https://www.balboapress.com/en/bookstore/bookdetails/797153-all-we-need-is-love.

 

“All We Need Is Love”

By Michele D. Baker

Softcover | 7.5×9.25 in | 142 pages | ISBN 9781982234560

E-Book | 142 pages | ISBN 9781982234577

Audiobook | ISBN 9781982251536

Available at Amazon and Barnes & Noble

 

About the Author

Michele D. Baker was raised in the Deep South and has always loved the written word. In her late 30s, she discovered she could hear and talk to angelic beings and has been given extraordinary information about the future of the planet. After a reluctant start, she has now joyfully accepted her assigned task and is thrilled to be spreading this exciting and life-changing message.

Balboa Press, a division of Hay House, Inc. – a leading provider in publishing products that specialize in self-help and the mind, body, and spirit genres. Through an alliance with the worldwide self-publishing leader Author Solutions, LLC, authors benefit from the leadership of Hay House Publishing and the speed-to-market advantages of the self-publishing model. For more information, visit balboapress.com. To start publishing your book with Balboa Press, call 844-682-1282 today.

Attachment



Marketing Services
Balboa Press
844-682-1282
[email protected]

Athena Gregory shares her journey of spiritual empowerment in ‘Goddess in Residence’

New autobiography inspires and empowers readers to awaken the Goddess hidden within

LOWER PLENTY, Australia, Jan. 07, 2021 (GLOBE NEWSWIRE) — In her first publishing foray, “Goddess in Residence” (published by Balboa Press AU), Athena Gregory takes readers through her journey of spiritual unfolding and empowerment as she navigates through life’s experiences.

 

The book begins with the author as a narrator who introduces her own life story and ends with her as a guide who shares her spiritual keys and codes. Here, readers enter the rich tapestry of her life’s journey, with the acts and scenes of an intriguing play taking them through three realms: the outer 3D material world and two inner realms of “the above” and “the below.” A comedy-tragedy-drama unfolds along her path to spiritual rebirth, and takes the reader to her awakening as an embodiment of Goddess. In a more empowered and authentic voice, the story concludes with a distilment of the author’s insights and deep experiences; sharing spiritual keys she calls Goddess Codes. 

 

“The global pandemic of 2020 has stirred people’s hearts and souls and the time is ripe for a deeper awakening to who we are as human beings and what we are doing here on this little blue green planet spinning round in this vast cosmos,” the author states. “I want my readers to see themselves in the twists and turns of my story, feel into what is universal in all of us and come closer to who they essentially are. I want them to become inspired by the spiritual keys I offer in my book… and receive the energy encoded within its pages. I want people to touch that special place in their soul that can activate their Inner Goddess.”

 

Deeply reflective with a unique theatrical twist, “Goddess in Residence” will appeal to people who are looking for a deeper meaning to their lives.  Purchase a copy at https://www.balboapress.com/en-au/bookstore/bookdetails/814748-goddess-in-residence.

 

“Goddess in Residence”

By Athena Gregory

Softcover | 6 x 9in | 248 pages | ISBN 9781504323239

E-Book | 248 pages | ISBN 9781504323246

Available at Amazon and Barnes & Noble

 

About the Author

Athena Gregory lives in the leafy outer suburbs of Melbourne, Australia. She has been married for almost four decades and has two adult sons; with her first grandchild on the way. She had her first metaphysical experience at the age of 21, with the passing of her father. This “seeing through the veils” was the catalyst that sparked her life-long journey of exploration and self-discovery. Through her learning and growth in various schools of philosophy, theosophy, esoteric yoga, Gnosis and tao, as well as various modalities of meditation, healing and the intuitive arts, she desired to pass it forward. As a result, she has been facilitating meditation and spiritual development classes, workshops and retreats, as well as supporting clients with energy healing and soul readings for over 20 years. Arriving at a point of spiritual integration, Gregory began to experience the Goddess hidden within all of creation — and ultimately within herself. She is now ready to share her wonderful palette of wisdom and empowering practices with widening circles of people. To know more about the author and her works, visit www.athenagregory.com.

Balboa Press Australia is a division of Hay House, Inc., a leading provider in publishing products that specialise in self-help and the mind, body and spirit genre. Through an alliance with the worldwide self-publishing leader Author Solutions, LLC, authors benefit from the leadership of Hay House Publishing and the speed-to-market advantages of the Author Solutions self-publishing model. For more information or to start publishing today, visit balboapress.com.au/ or call 1-800-844-925.

Attachment



Marketing Services
Balboa Press AU
1-800-844-925
[email protected]

OncoZenge announces issue of European Patent related to BupiZenge®

PR Newswire

STOCKHOLM, Jan. 7, 2021 /PRNewswire/ — OncoZenge AB (publ), Moberg Pharma’s subsidiary, today announced that the European Patent Office (EPO) has granted patent 3 284 459 which protects BupiZenge®, currently in development for treatment of pain due to oral mucositis. The patent is expected to be in effect until 2032.

The new patent protects sustained-release lozenge containing bupivacaine, for treatment or alleviation of pain in the oral cavity. It is a divisional of the previously granted European patent 2 701 681, that specifically protects the use of lozenges for treatment of pain due to oral mucositis for cancer patients. BupiZenge® has previously been granted patents with a similar scope in the United States and Canada.

The patent significantly strengthens the intellectual property for BupiZenge® in Europe“, Pirkko Tamsen, CEO of OncoZenge comments. “It protects the use of BupiZenge® in all relevant indications for treatment of pain in the oral cavity“.

About Oral Mucositis and BupiZenge®

Globally, around 5 million people suffer from Oral mucositis (“OM”) after cancer treatment. OM is an inflammation of the mucous membranes in the mouth and throat, which results in painful ulcers. OM is considered the most debilitating side effect of radiation therapy and chemotherapy and commonly occurs. After radiation therapy in the head and neck region, 90 percent of patients develop OM, and of the patients who are treated with chemotherapy around 30 percent are affected. OM causes severe pain, difficulty to swallow and talk, and can lead to interruptions in cancer treatment as well as increased health care costs.

The BupiZenge® technology encompasses novel lozenge formulations of bupivacaine, a local anesthetic with a well-established long acting effect, currently available on the market for other indications as an injectable. In a previous phase 2 study on cancer patients, BupiZenge® has demonstrated statistically significant pain relief in the oral cavity and throat; the pain level in the mouth was reduced by 50 percent. compared to the current treatment.

CONTACT:

For additional information, please contact:

Pirkko Tamsen

CEO OncoZenge
telephone: +46 760 09 84 99
e-mail: [email protected]

Anna Ljung

CEO Moberg Pharma
telephone: +46 707 66 60 30
e-mail: [email protected]

About this information

The information was submitted for publication, through the agency of the contact persons set out above, at 8.00 a.m. CET on January 7th, 2021.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/moberg-pharma/r/oncozenge-announces-issue-of-european-patent-related-to-bupizenge-,c3264095

The following files are available for download:


https://mb.cision.com/Main/1662/3264095/1356111.pdf

OncoZenge announces issue of European Patent related to BupiZenge®

 

Cision View original content:http://www.prnewswire.com/news-releases/oncozenge-announces-issue-of-european-patent-related-to-bupizenge-301202572.html

SOURCE Moberg Pharma

New fictional memoir discusses author’s odd experiences with her former husband, his sexual identity issues and his family

Christine Holly shows how she survived dysfunction while discovering her own co-dependent triggers

BALTIMORE, Jan. 07, 2021 (GLOBE NEWSWIRE) — A fictionalized memoir of Christine Holly’s life, “Crude Awakening” (published by Archway Publishing) shares the story of a conservative, Eastern Shore woman who marries into a presumed wholesome Christian farming family, only to discover she’s surrounded by dysfunction and fetishes.

 

When the naïve young woman relocates to Oklahoma to begin her life as a dutiful farm wife, she discovers that not all is as wholesome as the little white churches and local county fairs make things seem. In time she finds herself a stranger in a strange land, aligned with a family with strange attitudes and deviant secrets.

 

“It has elements of fiction, though it is based on actual events. While it’s a story of survival, it is also a story of the author’s own self-discovery,” Holly says, advising readers that “A person should take time to know everything about a person before they marry them — as well as know everything about themselves.”

 

“Crude Awakening” is available for purchase online at the Archway link above, at Barnes & Noble and on Amazon at: https://www.amazon.com/Crude-Awakening-Christine-Holly/dp/1480895539.

 

“Crude Awakening”

By Christine Holly

Hardcover | 5.5 x 8.5 in | 188 pages | ISBN 9781480895546

Softcover | 5.5 x 8.5 in | 188 pages | ISBN 9781480895539

E-Book | 188 pages | ISBN 9781480895553

Available at Amazon and Barnes & Noble

 

About the Author

Christine Holly lives in Eastern Maryland. She’s embarked on a new life, with a new career, new pets, and a new attitude toward living.

Simon & Schuster, a company with nearly ninety years of publishing experience, has teamed up with Author Solutions, LLC, the worldwide leader in self-publishing, to create Archway Publishing. With unique resources to support books of all kind, Archway Publishing offers a specialized approach to help every author reach his or her desired audience. For more information, visit www.archwaypublishing.com or call 844-669-3957.

Attachment



Marketing Services
Archway Publishing
844-669-3957
[email protected]